Three months of rifapentine and isoniazid for latent tuberculosis infection

Keyphrases

• Tuberculosis 100%
• Latent Tuberculosis Infection 100%
• Rifapentine 100%
• Therapy Groups 100%
• Combination Therapy 100%
• Treatment Completion 50%
• Cumulative Rates 50%
• Tuberculosis Control 25%
• High Risk 25%
• United States 25%
• Adverse Events 25%
• Treatment Efficacy 25%
• Disease Prevention 25%
• Centers for Disease Control 25%
• Canada 25%
• Intention-to-treat Analysis 25%
• Noninferiority Margin 25%
• Brazil 25%
• Low Dose Rate 25%
• Long-term Safety 25%
• Hepatotoxicity 25%
• Spain 25%
• Once-weekly 25%
• Tuberculosis Elimination 25%
• Non-inferiority Trial 25%
• Directly Observed 25%
• Safety Monitoring 25%
• Modified Intention-to-treat 25%
• Drug Discontinuation 25%
• Latent Mycobacterium Tuberculosis Infection 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Latent Tuberculosis 100%
• Isoniazid 100%
• Rifapentine 100%
• Combination Therapy 40%
• Adverse Event 10%
• Elimination 10%
• Hepatotoxicity 10%
• Noninferiority Trial 10%
• Diseases 10%